Ana Llorens

681 total citations
13 papers, 557 citations indexed

About

Ana Llorens is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Ana Llorens has authored 13 papers receiving a total of 557 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Ana Llorens's work include Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Ana Llorens is often cited by papers focused on Protease and Inhibitor Mechanisms (4 papers), Cell Adhesion Molecules Research (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Ana Llorens collaborates with scholars based in Spain, United States and Argentina. Ana Llorens's co-authors include Àngels Fabra, Antònia Vinyals, Amparo Cano, Eva Cubillo, Eva Valero, David Olmeda, Mireia Jordà, Albert Figueras, Jordi Graells and Abelardo Moreno and has published in prestigious journals such as PLoS ONE, Biochemical Journal and Journal of Cell Science.

In The Last Decade

Ana Llorens

11 papers receiving 548 citations

Peers

Ana Llorens
Lucie Kopfstein Switzerland
Yingshe Zhao United States
Brinda Alagesan United States
Erica Lorenzon Switzerland
Ana Llorens
Citations per year, relative to Ana Llorens Ana Llorens (= 1×) peers Antònia Vinyals

Countries citing papers authored by Ana Llorens

Since Specialization
Citations

This map shows the geographic impact of Ana Llorens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Llorens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Llorens more than expected).

Fields of papers citing papers by Ana Llorens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Llorens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Llorens. The network helps show where Ana Llorens may publish in the future.

Co-authorship network of co-authors of Ana Llorens

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Llorens. A scholar is included among the top collaborators of Ana Llorens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Llorens. Ana Llorens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Sardar, Sundus, et al.. (2024). Back to Basics: Multiple Episodes of Hyperkalemia Due to Different Etiologies All Explained by Basic Physiologic Principles. Journal of the American Society of Nephrology. 35(10S).
3.
Díaz‐Ramos, Angels, et al.. (2012). Requirement of Plasminogen Binding to Its Cell-Surface Receptor α-Enolase for Efficient Regeneration of Normal and Dystrophic Skeletal Muscle. PLoS ONE. 7(12). e50477–e50477. 12 indexed citations
4.
Jordà, Mireia, David Olmeda, Antònia Vinyals, et al.. (2005). Upregulation of MMP-9 in MDCK epithelial cell line in response to expression of the Snail transcription factor. Journal of Cell Science. 118(15). 3371–3385. 190 indexed citations
5.
López-Barcons, Lluís, et al.. (2005). Targeted adriamycin delivery to MXT-B2 metastatic mammary carcinoma cells by transferrin liposomes: Effect of adriamycin ADR-to-lipid ratio. Oncology Reports. 14(5). 1337–43. 4 indexed citations
6.
Graells, Jordi, Antònia Vinyals, Albert Figueras, et al.. (2004). Overproduction of VEGF165 Concomitantly Expressed with its Receptors Promotes Growth and Survival of Melanoma Cells through MAPK and PI3K Signaling. Journal of Investigative Dermatology. 123(6). 1151–1161. 122 indexed citations
7.
Llorens, Ana, Isabel Rodrigo, Lluís López-Barcons, et al.. (1998). Down-regulation of E-cadherin in mouse skin carcinoma cells enhances a migratory and invasive phenotype linked to matrix metalloproteinase-9 gelatinase expression.. PubMed. 78(9). 1131–42. 76 indexed citations
8.
Llorens, Ana, et al.. (1997). Metastatic ability of MXT mouse mammary subpopulations correlates with clonal expression and/or membrane-association of gelatinase A. Molecular Carcinogenesis. 19(1). 54–66. 8 indexed citations
9.
Mollinedo, Faustino, Motowo Nakajima, Ana Llorens, et al.. (1997). Major co-localization of the extracellular-matrix degradative enzymes heparanase and gelatinase in tertiary granules of human neutrophils. Biochemical Journal. 327(3). 917–923. 83 indexed citations
10.
Bonfil, R. Daniel, Antònia Vinyals, Oscar D. Bustuoabad, et al.. (1994). Stimulation of angiogenesis as an explanation of matrigel‐enhanced tumorigenicity. International Journal of Cancer. 58(2). 233–239. 42 indexed citations
11.
Tarrés, María Cristina, et al.. (1992). The eSS rat. A model of non-insulin-dependent human diabetes.. PubMed. 141(3). 761–3. 12 indexed citations
12.
Webb, Susan M., Isaac Lévy, John Wass, et al.. (1984). STUDIES ON THE MECHANISMS OF SOMATOSTATIN RELEASE AFTER INSULIN INDUCED HYPOGLYCAEMIA IN MAN. Clinical Endocrinology. 21(6). 667–675. 6 indexed citations
13.
Webb, Susan M., John Wass, Ana Llorens, et al.. (1983). Insulin induced somatostatin secretion in man is mediated by gastric acid. Regulatory Peptides. 5. 11–12. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026